Zhengye Biotechnology (ZYBT)
Develops veterinary vaccines for livestock and dogs in China.
$1.29
vs last close−0.06 (−4.67%)
In millions of USD, except per-share figures · converted from CNY at the latest rate
| In millions | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 |
|---|---|---|
| Revenue | 4 | 8 |
| Cost of revenue | 4 | 7 |
| Gross profit | 0 | 1 |
| 3 | 7 | |
| Research & development | 1 | 1 |
| 3 | 5 | |
| Selling & marketing | 2 | 0 |
| General & administrative | 1 | 0 |
| Operating income | −3 | −6 |
| 0 | 0 | |
| Interest income | 0 | 0 |
| Interest expense | 0 | 0 |
| Income before tax | −3 | −6 |
| Income tax expense | 1 | 2 |
| Net income from continuing operations | −4 | −8 |
| Net income | −4 | −7 |
| EPS, basic | −$0.08 | −$0.15 |
| EPS, diluted | −$0.08 | −$0.15 |
| Weighted average shares, basic | 47 | 47 |
| Weighted average shares, diluted | 47 | 47 |
| EBITDA | −2 | −4 |
| Depreciation & amortization | 1 | 2 |
| EBIT | −3 | −6 |